Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhancing Attention and Wellbeing Using Digital Therapeutics

NCT: NCT06397469 · RECRUITING

NCT IDNCT06397469
StatusRECRUITING
Start Date2024-04-01
Completion2029-06-01
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.

Frequently Asked Questions

What is Enhancing Attention and Wellbeing Using Digital Therapeutics?

Enhancing Attention and Wellbeing Using Digital Therapeutics is a clinical trial registered under NCT06397469. Current status: RECRUITING.

What is the status of NCT06397469?

The current status of NCT06397469 (Enhancing Attention and Wellbeing Using Digital Therapeutics) is: RECRUITING.

When did Enhancing Attention and Wellbeing Using Digital Therapeutics start?

Enhancing Attention and Wellbeing Using Digital Therapeutics started on 2024-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.